Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|10|1347-1350

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.10, 2015-03, pp. : 1347-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in the Discovery of Polo-like Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 181-197

Bentham Science Publishers

Access to resources Recommend Favorite

Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2014-2025

Bentham Science Publishers

Access to resources Recommend Favorite

Real-time Fluorescent Quantitative Polymerase Chain Reaction Study of Polo-like Kinase-1 in Pterygia

By Lu H   Lou DH   Zhu LL  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1851-1858

Field House Publishing

Access to resources Recommend Favorite

Association of spindle midzone particles with polo-like kinase 1 during meiosis in mouse and human oocytes

By Otsuki Junko   Nagai Yasushi   Chiba Kazuyoshi  

Reproductive BioMedicine Online, Vol. 18, Iss. 4, 2009-04 ,pp. : 522-528

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD)

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1194-1205

Bentham Science Publishers

Access to resources Recommend Favorite